Second Price Monitoring Extn | 05-Jan-2023 | 09:05 | RNS |
Price Monitoring Extension | 05-Jan-2023 | 09:00 | RNS |
Appointment of Non-Executive Director | 05-Jan-2023 | 07:01 | RNS |
Business Update | 05-Jan-2023 | 07:00 | RNS |
Issue of Equity | 02-Dec-2022 | 17:30 | RNS |
Second Price Monitoring Extn | 01-Nov-2022 | 16:41 | RNS |
Price Monitoring Extension | 01-Nov-2022 | 16:35 | RNS |
Issue of Equity | 21-Oct-2022 | 18:15 | RNS |
Streamlining of operations to increase cash runway | 18-Oct-2022 | 07:00 | RNS |
TR-1: Notification of major holdings | 17-Oct-2022 | 14:23 | RNS |
TR-1: Notification of major holings | 17-Oct-2022 | 14:23 | RNS |
Holding(s) in Company | 30-Sep-2022 | 17:30 | RNS |
Issue of Equity | 30-Sep-2022 | 17:30 | RNS |
Interim Results | 29-Sep-2022 | 07:00 | RNS |
Positive headline results from ovarian study | 29-Sep-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 13.63p |
Change Today | -0.38p |
% Change | -2.68 % |
52 Week High | 31.35 |
52 Week Low | 9.24 |
Volume | 721,053 |
Shares Issued | 319.08m |
Market Cap | £43.47m |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
12:15 | 13,500 @ 13.78p |
11:37 | 357 @ 14.00p |
11:36 | 10,000 @ 13.78p |
11:31 | 1,500 @ 13.90p |
11:14 | 14,388 @ 13.90p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research